BEVACIZUMAB COMBINED WITH PDT, VERSUS RANIBIZUMAB AND PEGAPTANIB BOTH COMBINED WITH PDT FOR NEOVACULAR AGE RELATED MACULAR DEGENERATION CLINICAL TRIAL

Registry ID

EUCTR2009-013062-11

Source registry

EUCTR

Status

Ongoing

Phase

PHASE3

Sponsor

AZIENDA USL 8 AREZZO

Start date

2007-03-29

Last update

2026-08-16

Conditions

• Neovascular Age Related Macular Degeneration

Summary

Compare efficacy and safety of the three treatments

Locations

• , , Italy

Related clinical trials

• A Study of PRL3-zumab in Neovascular Age-related Macular Degeneration (nAMD)
• Impact of Intravitreal Faricimab on Renal Function in Diabetic Patients

View on source registry